However, last year, two patients died from liver failure after receiving Elevidys. This led to Sarepta Therapeutics having to ...

Johnson & Johnson has increased its dividend each year for over half a century. The company has a very healthy financial profile. It has excellent growth prospects. The healthcare giant currently pays ...

Well, my prediction is Nvidia still has plenty of room to run, and it will do so in 2026 thanks to this one thing. First, ...

What's the once-in-a-decade investment opportunity of the current decade? Generative AI is a top candidate. However, quantum ...

That extra energy is enough to support seven deals like the Microsoft one. Iren is aiming for $3.4 billion in annual ...

This aspect of its business provides visibility into future earnings over the next decade and beyond. Right now, GE Vernova ...

Cloud security company Zscaler has racked up big returns for investors since going public in 2018. In this podcast, Jay Chaudhry, CEO, chairman, and founder of Zscaler, talks about entrepreneurship, ...

The Fidelity Wise Origin Bitcoin Fund tracks bitcoin directly, while the Bitwise Crypto Industry Innovators ETF invests in ...

Nvidia once generated most of its revenue by selling GPUs for gaming PCs. Today, it generates most of its revenue from the ...

While price is not the same as value, a couple of stocks that trade at less than $100 right now that could make for ...

Dividend stocks don't often offer the same thrill as cutting-edge technology tickers, but that's not to say they don't merit ...

Buying into it will quickly have you invested in 100 companies with at least 10 years of dividend increases. Top holdings ...